Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group. Issue 6 (December 2019)
- Record Type:
- Journal Article
- Title:
- Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group. Issue 6 (December 2019)
- Main Title:
- Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group
- Authors:
- Bradshaw, Daniel
Mbisa, Jean L
Geretti, Anna Maria
Healy, Brendan J
Cooke, Graham S
Foster, Graham R
Thomson, Emma C
McLauchlan, John
Agarwal, Kosh
Sabin, Caroline
Mutimer, David
Moss, Peter
Irving, William L
Barnes, Ellie - Abstract:
- Highlights: Consensus view from Public Health England's HCV Resistance Group. Review providing guidance on when and how to perform HCV resistance testing, and interpretation of results. Includes five key scenarios where HCV resistance testing is recommended in the UK and other similar settings. Abstract: The treatment of hepatitis C virus (HCV) infection has been revolutionised by the advent of oral, well-tolerated, direct acting antiviral therapies (DAA), with high cure rates. However, in some scenarios, HCV resistance to antiviral therapies may have an impact on treatment success. Public Health England's HCV Resistance Group was established to support clinicians treating people with HCV, where the issue of resistance may be a factor in clinical decision-making, and this review includes the Group's current recommendations on the use of HCV resistance testing. The authors describe the principles behind and approach to HCV resistance testing and consider evidence from in vitro studies, clinical trials and real world cohorts on the impact of HCV resistance on treatment outcomes for particular DAA regimens. Five scenarios are identified in the UK and similar settings, where, in the Group's opinion, resistance testing should be performed.
- Is Part Of:
- Journal of infection. Volume 79:Issue 6(2019)
- Journal:
- Journal of infection
- Issue:
- Volume 79:Issue 6(2019)
- Issue Display:
- Volume 79, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 79
- Issue:
- 6
- Issue Sort Value:
- 2019-0079-0006-0000
- Page Start:
- 503
- Page End:
- 512
- Publication Date:
- 2019-12
- Subjects:
- Hepatitis C virus -- Resistance testing -- Sequencing -- Direct acting antivirals
Infection -- Periodicals
Bacterial Infections -- Periodicals
Communicable Diseases -- Periodicals
Electronic journals
616.905 - Journal URLs:
- http://www.idealibrary.com/links/toc/jinf/ ↗
http://www.harcourt-international.com/journals ↗
http://www.sciencedirect.com/science/journal/01634453 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01634453 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01634453 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jinf.2019.10.007 ↗
- Languages:
- English
- ISSNs:
- 0163-4453
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.690000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12458.xml